ArticleScience translational medicine2025

An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer.

Kathleen M McAndrews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.